Eastwood Bio-Medical Canada Inc logo

Eastwood Bio-Medical Canada Inc

C$ 1.20 (0%) Sep 29
P/E:
At Loss
P/B:
0
Market Cap:
C$ 82.66M ($ 60.36M)
Enterprise V:
C$ 82.66M ($ 60.35M)
Volume:
-
Avg Vol (2M):
1.13K
Also Trade In:
Volume:
-
Market Cap C$:
82.66M
Market Cap $:
60.36M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.13K
Enterprise Value C$:
82.66M
Enterprise Value $:
60.35M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Eastwood Bio-Medical Canada Inc is engaged in the development and commercialization of safe and effective treatment for non-insulin-dependent diabetes mellitus (NIDDM-Type II diabetes). The company's Eleotin brand of products provides naturally sourced solutions for metabolic syndromes such as blood glucose control, obesity, and hypertension. Eleotin was initially developed by the scientists at the Julia McFarlane Diabetes Research Center (JMDRC) at the University of Calgary in Alberta, Canada. After the initial development by the JMDRC, research and development were continued by Eastwood Bio-Medical Research Inc., the company, and other institutions around the world, including Tsinghua University of the People's Republic of China.
Name Current Vs Industry Vs History
Cash-To-Debt 1.1
Equity-to-Asset -0.27
Debt-to-Equity -0.17
Debt-to-EBITDA -0.24
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 46.12
Distress
Grey
Safe
Beneish M-Score -0.57
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 1.71
9-Day RSI 19.21
14-Day RSI 33.84
6-1 Month Momentum % -7.41
12-1 Month Momentum % -21.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.17
Quick Ratio 0.17
Cash Ratio 0.04
Days Sales Outstanding 6.78
Days Payable 80.7

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
Gross Margin % 66.46
Operating Margin % -20.8
Net Margin % -19.47
ROA % -29.79
ROIC % -36.16
ROC (Joel Greenblatt) % -42.93
Name Current Vs Industry Vs History
PS Ratio 75
EV-to-EBIT -351.74
EV-to-EBITDA -645.78
EV-to-Revenue 73.15
EV-to-FCF -1450.18
Earnings Yield (Greenblatt) % -0.28

Financials

TSXV:EBM's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 1.13
EPS (TTM) (C$) -0.03
Beta 0.66
Volatility % 86.9
14-Day RSI 33.84
14-Day ATR (C$) 0.028002
20-Day SMA (C$) 1.21
12-1 Month Momentum % -21.88
52-Week Range (C$) 0.5 - 2
Shares Outstanding (Mil) 68.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Eastwood Bio-Medical Canada Inc Filings

Document Form Filing Date
No Filing Data

Eastwood Bio-Medical Canada Inc Analysis

Share your research